The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Contraceptive Drugs And Devices Market By 2030 Starting From Its 2026 Size?
The contraceptive drugs and devices market has shown significant growth in recent years. This market is set to increase from $26.98 billion in 2025 to $28.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. The expansion observed in the past can be credited to various elements, such as government-led family planning programs, increased understanding of reproductive health, rising urbanization and educational levels, wider availability of oral contraceptives, and public health campaigns advocating for birth control.
The contraceptive drugs and devices market size is anticipated to experience robust growth in the upcoming years, projected to reach $38.08 billion by 2030, at a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period can be attributed to factors such as increased digital health integration, a rising preference for non-invasive contraceptive methods, the proliferation of telehealth-based prescriptions, a heightened focus on research into male contraception, and supportive reproductive health policies. Noteworthy trends expected in this period include the increased adoption of long-acting reversible contraceptives, a growing use of hormonal combination therapies, a surge in demand for female-centric contraceptive solutions, the expansion of over-the-counter contraceptive products, and the increasing acceptance of digital contraceptive platforms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
Which Market Drivers Are Supporting The Expansion Of The Contraceptive Drugs And Devices Market?
An increasing volume of government programs concerning reproductive health is anticipated to fuel the expansion of the contraceptive drugs and devices market moving ahead. These governmental efforts advance reproductive well-being by fostering public understanding, providing financial support, and facilitating entry to relevant services. The proliferation of government programs focused on reproductive health stems from an increasing acknowledgment of the necessity to tackle matters like maternal wellness, family planning, and availability of vital healthcare provisions, all indispensable for collective societal health and advancement. The objectives of government projects for contraceptive drugs and devices include enhancing access to economical and efficient family planning options, thereby enabling individuals to make educated decisions regarding their reproductive health. As an illustration, in November 2024, the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, reported that Australia plans to commit $56.8 million to a fresh endeavor designed to advance sexual and reproductive health and rights across Southeast Asia. Consequently, the increasing frequency of governmental actions related to reproductive health is stimulating the growth of the contraceptive drugs and devices market.
Which Segment Categories Define The Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
What Major Market Trends Are Driving Changes In The Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible, contraceptive vaginal ring designed to be inserted into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control option that eliminates the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.
Who Are The Top Companies Competing In The Contraceptive Drugs And Devices Market?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
Read the full contraceptive drugs and devices market report here:
How Is The Contraceptive Drugs And Devices Market Distributed Across Key Geographic Regions?
North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Contraceptive Drugs And Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp
Browse Through More Reports Similar to the Global Contraceptive Drugs And Devices Market 2026, By The Business Research Company
Contraceptive Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptive-devices-global-market-report
Contraceptives Market Report 2026
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report
Oral Contraceptive Pills Market Report 2026
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model